Belgium-based ClimateCamp raises €700K to make food & beverages industry carbon neutral
ClimateCamp is prepared to expand to the larger European food and beverage sector, which is responsible for 37 per cent of the world’s carbon emissions.
Popular topics
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,932 articles · Funding
ClimateCamp is prepared to expand to the larger European food and beverage sector, which is responsible for 37 per cent of the world’s carbon emissions.
Scania claims to be a world-leading provider of transport solutions, including trucks and buses for heavy transport applications, combined with an extensive product-related service offering.
Helsinki-based Rive (formerly Kodit.io), a real estate services platform, announced on Wednesday that it has secured €23M in a Series A round of funding.
The war in Ukraine has led to a sharp increase in energy prices in the Netherlands.
Volta Trucks already has thousands of pre-orders for the full-electric Volta Zero.
Kiln believes that the staking market must go beyond operating validators and become institutionalised to satisfy the expanding consumer need for risk spreading.
OVHcloud claims to be the leading European cloud provider. The company operates over 450,000 servers within 33 data centres across four continents to reach 1.6 million customers.
Occtoo gives businesses the ability to link all of the data, content, and APIs from all systems in a low-code user interface.
Scantinel Photonics is a Frequency-Modulated Continuous Wave (FMCW) sensing technology company offering next-gen LiDAR solutions for autonomous mobility.
Amsterdam-based Buddee, an HR-tech startup, announced on Thursday that it has raised €1M in funding from a network of strategic angel…
Dronamics claims to be the world’s first cargo drone airline that develops and operates large, long-range drones.
Bayern-based CatalYm, a biotechnology company developing immunotherapies for cancer patients, announced on Tuesday, November 22, that it has secured €50M in a Series C round of funding.